Preliminary results of a Phase 1b, open-label, multicenter study of selgantolimod (GS-9688) in special populations of patients with chronic hepatitis B

被引：0
|
作者：
Agarwal, Kosh [1 ]
Cheng, Pin-Nan [2 ]
Liu, Chun-Jen [3 ,4 ]
Duan, Ran [5 ]
Kolhatkar, Nikita [5 ]
Mateo, Roberto [5 ]
Da, Ben [5 ]
Richards, Christopher [5 ]
Sowah, Leonard [5 ]
Fletcher, Simon [5 ]
Mendez, Patricia [5 ]
Chen, Chi-Yi [6 ]
Chuang, Wan-Long [7 ]
Holden Hsu, Yao-Chun [8 ,9 ]
机构：
[1] Kings Coll Hosp NHS Fdn Trust, Inst Liver Studies, London, England
[2] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Tainan, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan
[4] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
[5] Gilead Sci Inc, Foster City, CA USA
[6] Ditmanson Med Fdn Chiayi Christian Hosp, Div Gastroenterol & Hepatol, Dept Med, Chiayi, Taiwan
[7] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan
[8] E Da Hosp, Kaohsiung, Taiwan
[9] I Shou Univ, Kaohsiung, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-182
引用
收藏
页码：S1159 / S1160
页数：2
相关论文
共 50 条
  • [1] Mavorixafor for Patients with Chronic Neutropenic Disorders: Results from a Phase 1b, Open-Label, Multicenter Study
    Warren, Julia T.
    Walkovich, Kelly J.
    Bolyard, Audrey Anna
    Dickerson, Kathryn E.
    Walter, Jolan E.
    Cadavid, Diego
    Chapa, Eloisa
    Chen, Kelly
    MacLeod, Richard
    Peters, Katie
    Polisson, Richard
    Dale, David C.
    [J]. BLOOD, 2022, 140 : 1408 - 1410
  • [2] Therapeutic Potential of TLR8 Agonist GS-9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators
    Amin, Oliver E.
    Colbeck, Emily J.
    Daffis, Stephane
    Khan, Shahzada
    Ramakrishnan, Dhivya
    Pattabiraman, Divya
    Chu, Ruth
    Steuer, Holly Micolochick
    Lehar, Sophie
    Peiser, Leanne
    Palazzo, Adam
    Frey, Christian
    Davies, Jessica
    Javanbakht, Hassan
    Rosenberg, William M. C.
    Fletcher, Simon P.
    Maini, Mala K.
    Pallett, Laura J.
    [J]. HEPATOLOGY, 2021, 74 (01) : 55 - 71
  • [3] Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B
    Mackman, Richard L.
    Mish, Michael
    Chin, Gregory
    Perry, Jason K.
    Appleby, Todd
    Aktoudianakis, Vangelis
    Metobo, Sammy
    Pyun, Peter
    Niu, Congrong
    Daffis, Stephane
    Yu, Helen
    Zheng, Jim
    Villasenor, Armando G.
    Zablocki, Jeff
    Chamberlain, Jason
    Jin, Haolun
    Lee, Gary
    Suekawa-Pirrone, Kimberley
    Santos, Rex
    Delaney, William E.
    Fletcher, Simon P.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (18) : 10188 - 10203
  • [4] A PHASE 1B, OPEN-LABEL STUDY OF MAVORIXAFOR IN PATIENTS WITH CHRONIC NEUTROPENIC DISORDERS
    Warren, Julia
    Walkovich, Kelly
    Bolyard, Audrey Anna
    Dickerson, Kathryn
    Walter, Jolan
    Cadavid, Diego
    Chapa, Eloisa
    Chen, Kelly
    Dubuc, Susan
    MacLeod, Richard
    Peters, Katie
    Polisson, Richard
    Dale, David
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70 : S128 - S129
  • [5] Safety, Pharmacokinetics and Pharmacodynamics of Oral TLR8 Agonist GS-9688 in Patients with Chronic Hepatitis B: A Randomized, Placebo-Controlled, Double-Blind Phase 1b Study
    Gane, Edward J.
    Kim, Hyung Joon
    Visvanathan, Kumar
    Kim, Yoon Jun
    Nguyen, Anh-Hoa
    Joshi, Adarsh
    Reyes, Maribel
    Lau, Audrey H.
    Gaggar, Anuj
    Subramanian, Mani
    Roberts, Stuart Keith
    Lim, Young-Suk
    [J]. HEPATOLOGY, 2018, 68 : 238A - 239A
  • [6] PERIPHERAL IMMUNE RESPONSES TO TOLL-LIKE RECEPTOR 8 AGONIST GS-9688 IN PATIENTS WITH CHRONIC HEPATITIS B
    Brooks, Anna E.
    Verdon, Daniel
    Eom, Jennifer
    Ng, Jin
    Steemson, John
    Lau, Audrey H.
    Wallin, Jeffrey
    Gaggar, Anuj
    Kottilil, Shyam
    Poonia, Bhawna
    Dunbar, Rod
    [J]. HEPATOLOGY, 2019, 70 : 440A - 441A
  • [7] An Open-Label, Multicenter, Phase 1b Study of Daratumumab in Combination with Backbone Regimens in Patients with Multiple Myeloma
    Moreau, Philippe
    Mateos, Maria-Victoria
    Blade, Joan
    Benboubker, Lotfi
    de la Rubia, Javier
    Facon, Thierry
    Comenzo, Raymond L.
    Fay, Joseph W.
    Qin, Xiang
    Masterson, Tara
    Schecter, Jordan
    Ahmadi, Tahamtan
    San Miguel, Jesus
    [J]. BLOOD, 2014, 124 (21)
  • [8] Open-label Phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients
    Patel, Keyur
    Lim, Seng G.
    Cheng, Chow W.
    Lawitz, Eric
    Tillmann, Hans L.
    Chopra, Narinder
    Altmeyer, Ralf
    Randle, John C. R.
    McHutchison, John G.
    [J]. ANTIVIRAL THERAPY, 2011, 16 (08) : 1341 - 1346
  • [9] In vitro modulation by TLR8 agonist GS-9688 of multiple regulatory cell types in patients with chronic hepatitis B
    Amin, Oliver E.
    Colbeck, Emily
    Daffis, Stephane
    Pattabiraman, Divya
    Sitali, Colette
    Rosenberg, William
    Fletcher, Simon
    Maini, Mala
    Pallett, Laura J.
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E445 - E445
  • [10] An open-label, multicenter Phase 1b study of radium-223+paclitaxel in cancer patients with bone metastases
    Geva, R.
    Lopez, J.
    Danson, S.
    Joensuu, H.
    Peer, A.
    Harris, S. J.
    Souza, F.
    Ploeger, B. A.
    Pereira, K. M. C.
    Perets, R.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
12345